imipramine has been researched along with Cerebral Concussion in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshiro, Y | 1 |
| Sakurai, Y | 1 |
| Sato, S | 1 |
| Kurahashi, N | 1 |
| Tanaka, T | 1 |
| Kikuchi, T | 1 |
| Tottori, K | 1 |
| Uwahodo, Y | 1 |
| Miwa, T | 1 |
| Nishi, T | 1 |
1 other study available for imipramine and Cerebral Concussion
| Article | Year |
|---|---|
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
Topics: Animals; Antidepressive Agents; Brain Concussion; Magnetic Resonance Spectroscopy; Male; Mice; Mice, | 2000 |